vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Western Union CO (WU). Click either name above to swap in a different company.

Western Union CO is the larger business by last-quarter revenue ($982.7M vs $493.8M, roughly 2.0× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 6.6%, a 0.2% gap on every dollar of revenue. On growth, Western Union CO posted the faster year-over-year revenue change (0.0% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -1.9%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.

MD vs WU — Head-to-Head

Bigger by revenue
WU
WU
2.0× larger
WU
$982.7M
$493.8M
MD
Growing faster (revenue YoY)
WU
WU
+1.7% gap
WU
0.0%
-1.7%
MD
Higher net margin
MD
MD
0.2% more per $
MD
6.8%
6.6%
WU
Faster 2-yr revenue CAGR
MD
MD
Annualised
MD
-0.1%
-1.9%
WU

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MD
MD
WU
WU
Revenue
$493.8M
$982.7M
Net Profit
$33.7M
$64.7M
Gross Margin
Operating Margin
9.9%
12.5%
Net Margin
6.8%
6.6%
Revenue YoY
-1.7%
0.0%
Net Profit YoY
10.5%
-47.6%
EPS (diluted)
$0.40
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
WU
WU
Q1 26
$982.7M
Q4 25
$493.8M
$972.0M
Q3 25
$492.9M
$985.3M
Q2 25
$468.8M
$983.6M
Q1 25
$458.4M
$938.7M
Q4 24
$502.4M
$1.0B
Q3 24
$511.2M
$993.4M
Q2 24
$504.3M
$1.0B
Net Profit
MD
MD
WU
WU
Q1 26
$64.7M
Q4 25
$33.7M
$114.4M
Q3 25
$71.7M
$139.6M
Q2 25
$39.3M
$122.1M
Q1 25
$20.7M
$123.5M
Q4 24
$30.5M
$385.7M
Q3 24
$19.4M
$264.8M
Q2 24
$-153.0M
$141.0M
Gross Margin
MD
MD
WU
WU
Q1 26
Q4 25
33.6%
Q3 25
34.7%
Q2 25
34.6%
Q1 25
34.0%
Q4 24
35.0%
Q3 24
34.2%
Q2 24
35.0%
Operating Margin
MD
MD
WU
WU
Q1 26
12.5%
Q4 25
9.9%
19.1%
Q3 25
13.8%
20.5%
Q2 25
12.8%
19.6%
Q1 25
7.0%
18.9%
Q4 24
7.8%
17.5%
Q3 24
6.6%
16.6%
Q2 24
-31.3%
18.7%
Net Margin
MD
MD
WU
WU
Q1 26
6.6%
Q4 25
6.8%
11.8%
Q3 25
14.5%
14.2%
Q2 25
8.4%
12.4%
Q1 25
4.5%
13.2%
Q4 24
6.1%
37.9%
Q3 24
3.8%
26.7%
Q2 24
-30.3%
13.8%
EPS (diluted)
MD
MD
WU
WU
Q1 26
$0.41
Q4 25
$0.40
$0.36
Q3 25
$0.84
$0.43
Q2 25
$0.46
$0.37
Q1 25
$0.24
$0.36
Q4 24
$0.37
$1.14
Q3 24
$0.23
$0.78
Q2 24
$-1.84
$0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
WU
WU
Cash + ST InvestmentsLiquidity on hand
$375.2M
$909.2M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
$910.5M
Total Assets
$2.2B
$8.1B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
WU
WU
Q1 26
$909.2M
Q4 25
$375.2M
$1.2B
Q3 25
$340.1M
$947.8M
Q2 25
$224.7M
$1.0B
Q1 25
$99.0M
$1.3B
Q4 24
$229.9M
$1.5B
Q3 24
$103.8M
$1.1B
Q2 24
$19.4M
$1.0B
Total Debt
MD
MD
WU
WU
Q1 26
Q4 25
$570.5M
$2.9B
Q3 25
$577.2M
$2.5B
Q2 25
$583.9M
$2.5B
Q1 25
$590.5M
$2.5B
Q4 24
$597.1M
$3.0B
Q3 24
$2.1B
Q2 24
$2.1B
Stockholders' Equity
MD
MD
WU
WU
Q1 26
$910.5M
Q4 25
$865.9M
$957.8M
Q3 25
$890.7M
$925.4M
Q2 25
$833.8M
$883.6M
Q1 25
$789.2M
$939.4M
Q4 24
$764.9M
$968.9M
Q3 24
$732.5M
$652.7M
Q2 24
$706.5M
$440.8M
Total Assets
MD
MD
WU
WU
Q1 26
$8.1B
Q4 25
$2.2B
$8.3B
Q3 25
$2.2B
$7.8B
Q2 25
$2.1B
$8.0B
Q1 25
$2.0B
$8.3B
Q4 24
$2.2B
$8.4B
Q3 24
$2.1B
$7.7B
Q2 24
$2.0B
$8.0B
Debt / Equity
MD
MD
WU
WU
Q1 26
Q4 25
0.66×
3.01×
Q3 25
0.65×
2.70×
Q2 25
0.70×
2.83×
Q1 25
0.75×
2.61×
Q4 24
0.78×
3.04×
Q3 24
3.29×
Q2 24
4.88×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
WU
WU
Operating Cash FlowLast quarter
$114.1M
$109.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
3.39×
1.68×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
WU
WU
Q1 26
$109.0M
Q4 25
$114.1M
$135.4M
Q3 25
$137.3M
$260.4M
Q2 25
$137.2M
$-300.0K
Q1 25
$-117.5M
$148.2M
Q4 24
$133.0M
$134.0M
Q3 24
$91.8M
$212.1M
Q2 24
$107.0M
$-33.8M
Free Cash Flow
MD
MD
WU
WU
Q1 26
Q4 25
$115.5M
Q3 25
$252.7M
Q2 25
$-7.8M
Q1 25
$144.8M
Q4 24
$119.7M
Q3 24
$205.1M
Q2 24
$-38.9M
FCF Margin
MD
MD
WU
WU
Q1 26
Q4 25
11.9%
Q3 25
25.6%
Q2 25
-0.8%
Q1 25
15.4%
Q4 24
11.8%
Q3 24
20.6%
Q2 24
-3.8%
Capex Intensity
MD
MD
WU
WU
Q1 26
4.8%
Q4 25
2.0%
Q3 25
0.8%
Q2 25
0.8%
Q1 25
0.4%
Q4 24
1.4%
Q3 24
0.7%
Q2 24
0.5%
Cash Conversion
MD
MD
WU
WU
Q1 26
1.68×
Q4 25
3.39×
1.18×
Q3 25
1.91×
1.87×
Q2 25
3.49×
-0.00×
Q1 25
-5.66×
1.20×
Q4 24
4.36×
0.35×
Q3 24
4.72×
0.80×
Q2 24
-0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

WU
WU

Segment breakdown not available.

Related Comparisons